BridgeMD
New treatment option for Tracheostomized Patients
Official title High Flow Tracheal Oxygen for Weaning of Tracheostomized Patients
ClinicalTrials.gov ID: NCT07559591
What this study is testing
- What it's testing
- In this pilot randomized controlled trial (RCT), the investigators aim to explore the feasibility of conducting a powered RCT that examines the efficacy and safety of high flow tracheal oxygen (HFTO) in weaning critically ill tracheostomy patients from mechanical ventilation. Objective of the study 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults ≥ 18 years of age
- Intensive care unit (ICU) patients with tracheostomy inserted during the index ICU admission.
- Mechanically ventilated for ≤60 days.
- Successful spontaneous breathing trial for 1 hour.
You likely can't join if
- Planned tracheostomy post head and neck surgery with ICU stay less than 48 hours
- Patient transferred from another hospital only if the intubation and tracheostomy dates are unavailable, otherwise would be eligible.
- Patient with an imminent plan for palliation and comfort care.
- Patient or substitute decision-maker declines consent to the study.
- The treating physician declines consent to the study.
The study team makes the final eligibility decision.
Where it's taking place
- Riyadh, Saudi Arabia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Riyadh, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.